on behalf of the participants R ecognizing the considerable excess burden of both cerebrovascular and lower extremity arterial disease suffered by persons with insulindependent or non-insulin-dependent diabetes mellitus,1,2 a workshop was convened to 1. Provide a current review of the knowledge pertaining to the prevalence, incidence, and risk factor associations of cerebral and peripheral vascular disease in diabetes and 2. Review and make recommendations about the methodology for identifying and quantifying lower extremity arterial disease in either the clinical or research setting.
Dr. Curb reviewed the current state of knowledge concerning the epidemiology of stroke in diabetes. Data from Framingham, the National Health and Nutrition Examination Survey, and the Systolic Hypertension in the Elderly Program suggest a twofold increase in relative risk for stroke in subjects with diabetes, although in a further study (the Rancho Bernardo Study) only a small increase was seen for women with diabetes. Data from the Honolulu Heart Study supported a relative risk of around 2 for persons with diabetes for developing stroke, and in common with some earlier reports also suggest that the relative risk is not increased for the subgroup with hemorrhagic stroke. This is particularly true after adjustment for other risk factors. The reasons for this observation remain obscure and should be studied further. One possible explanation suggested was that the hypercoagulable state seen in some patients with diabetes may reduce the risk of bleeding.
Two presentations then focused on the epidemiology of risk factors for lower extremity arterial disease. Dr. Palumbo reported data from the diabetes incidence cohort of Rochester, Minn.2,4-6 Eight percent of subjects had LEAD at the time of diagnosis of diabetes. The cumulative incidence of LEAD rose with age and duration of diabetes to reach 45% by 20 years of duration of diabetes. In a multivariate analysis of a cohort comprising both nondiabetic and diabetic subjects with and without LEAD at baseline, progression of LEAD was related to the presence of both LEAD and diabetes at baseline, decreased postexercise ankle-brachial index (ABI), increased systolic blood pressure, and smoking. Diabetes control (glycated hemoglobin) and lipoprotein profile did not contribute further to the prediction of progression of LEAD.
In the Schwabing studies reported by Dr. Janka, more than 600 patients with either insulin-dependent or non-insulin-dependent diabetes mellitus were prospectively followed up for LEAD by ultrasonic Doppler measurements.78 At the 5-year, as well as a 9-year follow-up, the incidence of mostly asymptomatic LEAD was consistently and significantly associated with base-line systolic blood pressure and the dyslipemic complex of high serum triglycerides/low high-density lipoprotein cholesterol level but not with total cholesterol level, weight, or diastolic blood pressure. The association with hemoglobin A1, plasma C-peptide, and daily insulin dose (in insulin-treated patients with non-insulindependent diabetes mellitus) was weaker and at 9-year follow-up only significant in univariate analysis. Sixtyseven percent of diabetic patients dying from cardiovascular causes within the 5-year observation had LEAD (mostly asymptomatic) at baseline compared with 15% in those who survived.
The clinical aspects of lower extremity arterial disease in diabetes were reviewed by Dr. Graor. An increase in hospital mortality and higher amputation rates amongst those with diabetes was stressed, as well as the higher proportion of diabetic subjects with stenoses in the medium-sized arteries below the knee. The importance of determining the neuropathic as well as the ischemic status of any diabetic subject with foot ulcers was also stressed, as was the need for protective care for any subject with neuropathic lesions.
Attention then turned to methodological issues, Dr. Lassen provided an overview of atraumatic methods for measuring cerebral blood flow. The xenon 133 inhalation method showed normal cerebral blood flow in long-term diabetes. This was the case even in most patients with extracranial atherosclerotic occlusive disease. However, a defect in cerebral blood flow autoregulation may be present, as manifested by the variation in cerebral blood flow that is observed with blood pressure variations. This defect, that also has been shown by other techniques, probably reflects increased stiffness of the hyalinized arterioles. The ill-defined syndrome of diabetic encephalopathy, a form of vascular dementia in very-long-duration insulin-dependent diabetes, may be related to these arteriolar changes, that set the stage for subcortical lesions, particularly lacunar infarcts.
The role of the clinical exam for LEAD was reviewed by Dr. Criqui.9 Using data from an elderly, populationbased cohort of more than 500 subjects (5% of whom had diabetes), clinical signs and symptoms were correlated with LEAD defined by segmental blood pressure ratio and flow velocity assessed by Doppler ultrasound. The recording of a pulse deficit had a low predictive value for LEAD. The sensitivity of the Rose Questionnaire for detecting LEAD was 9% while only 20% of those with LEAD had exercise calf pain not present at rest. These low values were partly explained by a high portion of LEAD being due to isolated disease in the posterior tibial artery which would not lead to exerciseinduced calf pain. A decreased or absent posterior tibial pulse had a relatively high sensitivity (71%) for LEAD and a fair (50%) positive predictive value. Dr. Criqui stressed that even isolated posterior tibial disease carried a threefold risk of all-cause mortality and a fourfold risk of coronary heart disease mortality.
The usefulness of the ankle:arm blood pressure index (ABI) was discussed in a presentation by Dr In the final presentation of data, Dr. Hiatt confirmed that there was a weak relation between the resting and postexercise ABIs in a population-based study of both diabetic and nondiabetic subjects from the San Luis Valley Diabetes Study.14 Subjects diagnosed as having peripheral arterial disease by the resting ABI did not necessarily have an abnormal postexercise ABI (the converse was also true). Additional findings from this study concerned the development of criteria for an abnormal ABI. Normal ranges for resting ABI were determined from a healthy, nondiabetic control subset of the study population. This analysis revealed that women had lower ABIs than men and that the ABI derived from the dorsalis pedis artery was lower than the ABI from the posterior tibial artery. These findings raise the need for further investigation as to whether definitions of an abnormal ABI should be both genderand vessel-specific.
Recommendations Based on the data presented at the workshop, previshop participants developed the following recommendations for the detection and follow-up of LEAD in the primary care setting and for more detailed assessment after referral to a specialized vascular clinic. In addition, further comments are provided to help extend the recommendations made for use in the detection of LEAD in the primary care setting to use in epidemiological studies.
Recommendations for the Detection and Follow-up of LEAD in Diabetic Subjects Being Followed in a Primary Care Setting (Items 1 through 4 can be addressed as part of the generally recommended annual physical examination for patients with diabetes).
Claudication
On an annual basis, diabetic patients should be asked about the presence of exercise-induced calf leg pain not present at rest. Patients with lifestyle-limiting exerciseinduced calf pain should be referred for specialist vascular assessment. The assessment may be at a vascular laboratory or clinic or by a specialist, depending on local facilities and physician preference. Specialist vascular assessment will allow confirmation of LEAD, disease localization, and possible determination of the toe systolic blood pressure (TSBP). The TSBP will permit a more accurate assessment of vascular status independent of medial wall calcification. Measurement of an ABI or referral for specialist vascular assessment should also be considered for patients with any leg pain not clearly ascribed to a nonvascular cause. The ABI, which should be assessed according to the protocol described later in this article, will help determine whether this pain may be due to ischemia. Because ischemic leg pain has a negligible prevalence in diabetic children, this recommendation is limited to patients with insulin-dependent or non-insulin-dependent diabetes 18 years old or older.
Signs of Critical Ischemia
The presence of any potential signs of critical ischemia, ie, foot or limb ulceration, the presence of skin changes (nail or skin atrophy, or dependent rubor), or the detection of gangrene, should lead to a referral for specialist vascular assessment. Because of the potential for medial wall calcification to raise systolic ankle pressure above the normal range even in the presence of occlusive disease, the ABI alone may not be sufficient to detect vascular insufficiency. Further testing, eg, TSBP, may be indicated (see below).
Palpation of Peripheral (Tibialis Posterior and Dorsalis Pedis) Pulses
Palpation of leg pulses should be performed on an annual basis for all adult patients (18 years old and older) with diabetes. An absent or decreased tibialis posterior pulse is an indication for performing an ABI (see "Ankle Brachial Index" below) or referral to a vascular laboratory for evaluation if the ABI cannot be determined by the primary physician. It is further recommended that, whenever possible, the presence of decreased or absent pulses be confirmed by a second ous published data, and extensive discussion, the workobserver or repeat examination before referral.
Palpation of peripheral pulses has a limited but useful place in the detection of LEAD. Although repeatability and interobserver agreement are low, sensitivity and positive predictive value are moderate for the detection of LEAD; therefore a significant number of cases will be identified by detection of a reduction or absence of these pulses. Furthermore, the presence of these pulses in low-risk diabetic subjects helps to confirm the absence of significant disease. It should be noted that the dorsalis pedis pulse is sometimes congenitally absent.
Femoral Bruits
Auscultation for femoral bruits on an annual basis is recommended for all adult patients with diabetes. The detection of femoral bruits is an indication for performing an ABI (see "Ankle Brachial Index" below) or, if that is not possible, referral to a vascular laboratory. Although it is recognized that auscultation for femoral bruits has similar difficulties to those described for pulse palpation, it nonetheless has sufficient sensitivity to merit its performance on an annual basis.
Ankle Brachial Index
It is recommended that all physician offices providing routine care to adult diabetic patients should be LEAD and medial arterial wall calcification are often associated (especially in patients with insulin-dependent diabetes mellitus) with an increased prevalence of nephropathy, proliferative retinopathy, and neuropathy.13 Therefore, it is strongly recommended that, at a minimum, existing guidelines for detection of these complications be followed. Guidelines currently exist for neuropathy2 '6,27 and Intermittent claudication. It is recognized that exercise-induced leg pain is a common sequela of arterial narrowing and occlusion at one or more levels of the arterial blood supply to the leg. The extent to which further testing needs to be done will depend on the severity of the problem, particularly as it relates to daily activity. In general terms, those patients whose exerciseinduced pain affects their life-style will deserve the most complete evaluation. The most common site for exercise-induced pain is the calf, but it can also develop in the thigh, hip, or buttock when the disease is localized above the inguinal ligament. Often the pain will start in the calf and then progress to the thigh and/or buttock if exercise is continued despite the onset of pain. It must be remembered that severe claudication is most often the result of multilevel arterial disease, which can be best evaluated in the noninvasive laboratory.
Critical ischemia. The clinical definition of critical ischemia is a clinical presentation that, if not reversed, is likely to result in an amputation either at the level of the foot or below the knee. In some rare cases amputation may be required at the above-knee level. Because therapy is so critical for limb preservation, it is essential that patients with critical ischemia have a complete noninvasive evaluation before arteriography (unless life-threatening infection is present, in which case immediate arteriography may be indicated). The categories of presentation that are relevant to this subset of patients are as follows: * Ischemic rest pain: In this setting, the pain will be in the toes and forefoot. It will, during its early phases, be relieved by dependency. If it does not improve with development of collateral circulation, amputation will be inevitable unless some form of intervention (surgical or endovascular) is carried out.
* Ulceration: When a break in the skin occurs at any location of the foot or lower leg, healing might not occur unless some form of intervention is carried out. The single exception may be for a patient who has an ulcer over a pressure point or site of direct injury that is secondary to neuropathy. However, it must be remembered that ischemia and neuropathy may coexist making patients in this subset candidates for amputation, unless the areas of occlusion are either bypassed or eliminated by transluminal angioplasty.
* Gangrene: Tissue death, when it involves one or more toes or the forefoot, will require amputation that may be limited to the involved areas if direct intervention can bring more blood to the ischemic area. * Skin changes: Although not as definitive as the preceding three categories, skin atrophy, nail changes, and dependent rubor occur in some patients who may require further evaluation. This is particularly true if the ABI is found to be abnormal.
Abnormal ABI. In the absence of any of the above conditions, a referral to a vascular laboratory is recommended for patients whose ABI is confirmed to be <0.50 in one or more vessels. This will permit confirmation, localization of the lesion, and possible assessment of toe systolic blood pressure index (TSPI) and will provide a more accurate picture of vascular status independent of medial arterial wall calcification.
The finding of incompressible arteries (ie, systolic blood pressure >300 mm Hg) at the level of the ankle makes it impossible to estimate the systolic pressure. In some cases the arteries may be compressible but give falsely high levels of recorded pressure. If the ankle systolic pressure is >75 mm Hg higher than the arm systolic pressure and/or the ABI is >1.30, medial arterial wall calcification is virtually certain and measurement of the TSPI in the vascular laboratory should be performed.
Recommended Vascular Laboratory Studies
Studies done in the resting state. It is possible to determine the severity of the occlusive disease by a combination of measurement of the ABI and the TSBI. It is recommended that both tests be done to provide confirmation of the vascular status. There are various cutoff levels that must be considered in conducting these tests. These are as follows:
* ABI: If the ABI is <0.90, occlusive arterial disease may be present. If a value of <0.80 is noted, it is highly likely that vascular disease will be found. ABIs between 0.50 and 0.80 are likely to be found in patients with single segment occlusions, while ABIs <0.50 are commonly found in patients with multisegment disease.
* TSPI: When measurements are made at the level of the toes, there are two cutoffs of clinical value. Firstly, for screening purposes a TSPI of >0.60 is normal. The variability in this measurement is + 17%. Secondly, the absolute levels of systolic pressure are of great value in estimating healing potential when an ulceration is found. If the absolute pressure is c30 mm Hg, healing is unlikely to occur unless some form of direct intervention is carried out.
* Alternative forms of study: The ABI is an overall indicator of obstructive disease in the legs, the aorta, or both. Thus, other supplemental modalities are desirable. Measurement of segmental systolic pressures permits, to some degree, the localization of sites of arterial occlusion in the limbs and may provide a more sensitive indicator of progression. Similarly, pulse volume recording taken at several levels of the limb is largely a qualitative testing procedure that provides data on the pattern of volume changes in response to pressure changes. The waveforms recorded will reflect underlying occlusive disease but are rarely specific as to exact sites of occlusion.
Another widely used method is velocimetry using continuous wave Doppler techniques. By using systems that permit an accurate display of the velocity patterns (fast fourier transform spectral analysis) it is possible to confirm the presence of arterial disease at or proximal to the recording sites. The procedure can be used at the femoral, popliteal, and tibial arteries at the ankle. Loss of the normal triphasic waveforms normally seen can be taken as certain evidence of arterial disease.
Because the ABI and TSPI provide quantitative indexes, they are to be considered the definitive diagnostic studies. The more qualitative tests can be added to provide additional information.
Exercise testing. Not all patients with exercise-induced leg pain will have arterial occlusive disease as the cause. It is well known that neurospinal disease and musculoskeletal disorders can also lead to leg pain and can be confused with true vascular intermittent claudication. When the etiology is uncertain, the cause can be elucidated by exercise testing.
The separation becomes possible because intermittent claudication secondary to arterial disease is always accompanied by a decrease in ankle systolic pressure after exercise. This is a stress test, but the levels of exercise required to make this distinction are minimal.
Although several methods of exercise can be used to bring out the abnormality associated with arterial disease, it is recommended that a treadmill be used with a standard elevation and speed. A speed of 2 mph at a 12% elevation is most commonly used. This speed and elevation can be tolerated by nearly all patients but can be decreased if the user desires. Regardless of the speed and elevation, it is important that the patient walk to the point of pain and preferably to the point of being unable to continue or for a full 5 minutes. It has been found that periods of walking in excess of 5 Cuffs. The same cuffs used for measurement of arm blood pressure should be used at the ankle. Similar concerns with regard to the need for appropriate-size cuffs for obese arms apply also to the ankle, and an appropriate cuff the width of which approximates 40% of the limb in circumference should be used at both sites.30 In most cases a regular arm blood pressure cuff will be adequate.
Method of measurement. There are several aspects of pressure measurement that must be observed if the examiner is to obtain the best and most reproducible results. The recommendations are as follows:
1. The pressures should be measured in both arms; use the higher of the two.
2. It is preferable to have the patient rest, quiet and supine, for at least 5 minutes before the pressures are measured. This ensures that any changes in pressure that might have occurred due to previous walking have a chance to stabilize.
3. The Doppler transducer should be placed at an angle of 600 to the artery being tested so that the best velocity signals will be obtained. If the transducer is at right angles to the artery, the detected velocity (frequency shift) will be at a minimum and often difficult to hear, particularly if the velocities are reduced secondary to arterial disease proximal to the recording site. In addition, care must be taken to maximize the Doppler signal by moving the probe back and forth over the artery to obtain the loudest signal. Failure to do so may result in underestimation of the arterial pressure measurement.
4. To obtain the most reproducible and accurate measurements the following rules must be followed: *The pressure must be taken at the point at which the Doppler signal first appears during deflation of the cuff (ie, pressure is never taken during cuff inflation).
* The cuff should be inflated to at least 20 mm Hg above arm systolic pressure levels to ensure complete collapse of the dorsalis pedis and posterior tibial arteries.
* The pressure that is recorded is taken at the point at which flow returns as detected by the Doppler system. * Cuff deflation must be slow (2 mm Hg/second) to accurately determine the point at which flow is restored.
* It is mandatory that the Doppler system also be used to measure the arm systolic pressure. To determine the arm pressure, the examiner may use either the brachial artery distal to the cuff or the radial artery at the wrist.
When the arterial signals at the level of the ankle cannot be obliterated by cuff inflation (pressure is >300 mm Hg), this is conclusive evidence that medial calcification is present. Similarly, when the ankle pressure is >75 mm Hg above the arm pressure or the ABI is >1.3, partial incompressibility due to medial calcification is likely to be present, giving rise to falsely high ankle pressure.
Appendix B Protocol for Measurement of Toe Systolic Blood Pressure Instrumentation. A strain gauge or a photoplethysmograph can be used as a sensor. (The strain gauge is also practical for measurement of ankle blood pressure). The cuff used to measure toe blood pressure should be 2.4 cm wide by 10 cm long (encircling the first toe).
Measurement. To obtain useful and reproducible results, the following aspects must be observed:
1. It is preferable to have the patient rest, quiet and supine, for at least 5 minutes before the pressures are measured.
2. Room temperature should be comfortable (more than about 220C) so the patient does not feel cold.
